Hospital Universitario de Octubre

Madrid 28041

0 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC), Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

Studies at this site

• A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed
• A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed